Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hepatitis C Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hepatitis C Drugsmarket, defines the market attractiveness level of Hepatitis C Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hepatitis C Drugs industry, describes the types of Hepatitis C Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hepatitis C Drugs market and the development prospects and opportunities of Hepatitis C Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hepatitis C Drugs market in Chapter 13.
By Player:
Novartis
Bristol-Myers Squibb
Merck
Gilead sciences
Johnson & Johnson
Abbvi
Roche
Glaxosmithkline
By Type:
Anti-Viral
Immuno-modulators
Others
By End-User:
Hospitals
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hepatitis C Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hepatitis C Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hepatitis C Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hepatitis C Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hepatitis C Drugs Market Analysis and Outlook to 2022
-
7.1 Global Hepatitis C Drugs Consumption (2017-2022)
-
7.2 United States Hepatitis C Drugs Consumption (2017-2022)
-
7.3 Europe Hepatitis C Drugs Consumption (2017-2022)
-
7.4 China Hepatitis C Drugs Consumption (2017-2022)
-
7.5 Japan Hepatitis C Drugs Consumption (2017-2022)
-
7.6 India Hepatitis C Drugs Consumption (2017-2022)
-
7.7 South Korea Hepatitis C Drugs Consumption (2017-2022)
8 Region and Country-wise Hepatitis C Drugs Market Analysis and Outlook to 2028
-
8.1 Global Hepatitis C Drugs Consumption Forecast (2022-2028)
-
8.2 United States Hepatitis C Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Hepatitis C Drugs Consumption Forecast (2022-2028)
-
8.4 China Hepatitis C Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Hepatitis C Drugs Consumption Forecast (2022-2028)
-
8.6 India Hepatitis C Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Hepatitis C Drugs Consumption Forecast (2022-2028)
9 Global Hepatitis C Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Hepatitis C Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-Viral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immuno-modulators Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hepatitis C Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Hepatitis C Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Hepatitis C Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-Viral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immuno-modulators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hepatitis C Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Hepatitis C Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hepatitis C Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hepatitis C Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hepatitis C Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hepatitis C Drugs Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Hepatitis C Drugs Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Hepatitis C Drugs Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Hepatitis C Drugs Product and Service
-
14.4 Gilead sciences
-
14.4.1 Gilead sciences Company Details
-
14.4.2 Gilead sciences Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Gilead sciences Hepatitis C Drugs Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Hepatitis C Drugs Product and Service
-
14.6 Abbvi
-
14.6.1 Abbvi Company Details
-
14.6.2 Abbvi Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Abbvi Hepatitis C Drugs Product and Service
-
14.7 Roche
-
14.7.1 Roche Company Details
-
14.7.2 Roche Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Roche Hepatitis C Drugs Product and Service
-
14.8 Glaxosmithkline
-
14.8.1 Glaxosmithkline Company Details
-
14.8.2 Glaxosmithkline Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Glaxosmithkline Hepatitis C Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hepatitis C Drugs
-
Figure Hepatitis C Drugs Picture
-
Table Global Hepatitis C Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatitis C Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatitis C Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hepatitis C Drugs Consumption by Country (2017-2022)
-
Figure United States Hepatitis C Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Hepatitis C Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Hepatitis C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Hepatitis C Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Hepatitis C Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hepatitis C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Hepatitis C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hepatitis C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hepatitis C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hepatitis C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hepatitis C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hepatitis C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Viral Consumption and Growth Rate (2017-2022)
-
Figure Global Immuno-modulators Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Viral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immuno-modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hepatitis C Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hepatitis C Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Hepatitis C Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Hepatitis C Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Hepatitis C Drugs Product and Service
-
Table Gilead sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead sciences Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead sciences Hepatitis C Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Hepatitis C Drugs Product and Service
-
Table Abbvi (Foundation Year, Company Profile and etc.)
-
Table Abbvi Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvi Hepatitis C Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Hepatitis C Drugs Product and Service
-
Table Glaxosmithkline (Foundation Year, Company Profile and etc.)
-
Table Glaxosmithkline Hepatitis C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glaxosmithkline Hepatitis C Drugs Product and Service
-
